Total Funding
62
78
Total FundingGrant raised
Growth Score
-1 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
38845
VasoRx is developing RNA therapies for diseases of the cardiovascular system & oncology such as atherosclerosis and pulmonary hypertension.
- Michael Simons: Co-Founder & Chairman of Scientific Advisory Board
Daniel Anderson: Co-Founder & Member of Scientific Advisory Board
About the Company
VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading the translation of technologies discovered at Massachusetts Institute of Technology (M.I.T) and Yale for the delivery of RNAs for the treatment of diseases. With the world’s first approved RNAi therapeutic, the field of RNA medicines is rapidly expanding.
VasoRx utilizes novel nanoparticles that are dramatically expanding the opportunities for developing RNA therapies for diseases of the cardiovascular system as well as oncology.
system & oncology such as atherosclerosis and pulmonary hypertension.
Women Founded
